Wellbutrin Dosing for a 16-Year-Old
For a 16-year-old adolescent, bupropion (Wellbutrin) should be initiated at 150 mg once daily in the morning for 3 days, then increased to 150 mg twice daily if tolerated, with a maximum dose of 300 mg per day. This dosing applies whether treating for depression, ADHD, or smoking cessation 1.
Dosing Algorithm
Initial Dosing
- Days 1-3: 150 mg once daily in the morning
- Day 4 onward: 150 mg twice daily (if tolerated)
- Maximum daily dose: 300 mg per day
This titration schedule comes from the most recent (2025) American Thoracic Society guideline specifically addressing adolescents ages 10-18 1. The guideline notes that sustained-release (SR) bupropion at 300 mg/day appears well tolerated in this age group 1.
Formulation Considerations
Extended-release formulations (Wellbutrin XL) may be dosed once daily at 150 mg, though the evidence base in adolescents primarily used SR formulations requiring twice-daily dosing 2, 3. The second dose should be given before 3 PM to minimize insomnia risk 4.
Clinical Context by Indication
For Depression
The 2018 GLAD-PC guidelines do not specifically recommend bupropion as a first-line agent for adolescent depression, favoring SSRIs instead 5. However, retrospective data from 127 youth (mean age 15.3 years) showed that bupropion at a mean dose of 180 mg/day (range 75-300 mg) significantly reduced depression severity over 12 weeks, with 45.7% achieving response 6. This suggests bupropion may be considered when SSRIs are contraindicated or ineffective.
For ADHD
Multiple studies support bupropion's efficacy for adolescent ADHD at doses up to 300 mg/day 7, 8, 9. One study used flexible dosing up to 3 mg/kg twice daily (mean final doses: 2.2 mg/kg morning, 1.7 mg/kg afternoon) in adolescents aged 11-16 8. However, the practical maximum remains 300 mg/day total.
For Smoking Cessation
The 2025 ATS guideline suggests a trial of bupropion for adolescents 10-18 years using nicotine/tobacco products, despite very low-certainty evidence 1. Studies used 150-300 mg/day for 6 weeks 1. The 2016 NCCN and 2019 ACC/AHA guidelines provide adult dosing (150 mg once daily for 3 days, then 150 mg twice daily) but do not address pediatric use 10, 11, 10.
Critical Safety Considerations
Absolute Contraindications
- Seizure disorder or history of seizures (bupropion lowers seizure threshold) 1
- Current or prior bulimia or anorexia nervosa (higher seizure incidence) 1
- Concurrent MAO inhibitor use 10
Important Warnings
Monitor closely for neuropsychiatric symptoms: The FDA previously had a black box warning (now removed) regarding depression, suicidal ideation, and behavioral changes 10, 11, 10. In the retrospective study of 127 youth, 16.3% had suicidal ideation and 5.9% had poisoning diagnoses prior to bupropion initiation 12. Close monitoring is essential, especially in the first weeks.
Eating disorders: In the same cohort, 2.2% had anorexia or bulimia nervosa diagnoses 12, which are contraindications.
Common Adverse Effects
The most common adverse effect in adolescents is irritability (9.4%), which typically resolves spontaneously or with discontinuation 6. Other reported effects include headache, though this was less common than with methylphenidate in head-to-head trials 9.
Pharmacokinetic Considerations
Adolescents metabolize bupropion faster than adults, with shorter half-lives for both bupropion (12.1 hours) and its metabolites 3. The active metabolite hydroxybupropion achieves levels 20 times higher than parent bupropion and likely contributes significantly to therapeutic effects 2, 3. This supports twice-daily dosing in adolescents rather than once-daily extended-release formulations.
Treatment Duration and Response Assessment
- Assess response at 4-6 weeks after reaching target dose
- Continue for at least 6 months if effective (39-45% of patients remain on treatment for ≥6 months across indications) 12
- Discontinuation rate: In the retrospective study, 36.2% discontinued before 12 weeks (19 due to adverse events, 15 due to poor effectiveness) 6
Practical Prescribing Notes
- Bupropion extended-release 150 mg is the most commonly prescribed formulation (62% of initiators) 12
- 22% of adolescent bupropion users are on concurrent SSRI treatment 12
- The medication should be taken in the morning (and early afternoon for second dose) to avoid insomnia
- Taper slowly when discontinuing to avoid withdrawal effects
The evidence supporting bupropion use in adolescents is of low to very low quality, but clinical experience and available data suggest benefits outweigh risks when used appropriately with close monitoring 1.